Vtv Therapeutics Inc. · NASDAQ:VTVT
Raymond Debbane reported a 9.40% stake in Vtv Therapeutics Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 12, 2025
Raymond Debbane reported a 9.40% stake in Vtv Therapeutics Inc., 393,098 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 393,098
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invus Public Equities, L.P. | 8.40% | 345,926 |
| Invus Public Equities Advisors, LLC | 8.40% | 345,926 |
| Invus Global Management, LLC | 8.40% | 345,926 |
| Siren, L.L.C. | 8.40% | 345,926 |
| Avicenna Life Sci Master Fund LP | 1.20% | 47,172 |
| Avicenna Life Sci Master GP LLC | 1.20% | 47,172 |
| Ulys, L.L.C. | 1.20% | 47,172 |
| Raymond Debbane | 9.40% | 393,098 |
Source
Related
- Vtv Therapeutics Inc.
- Invus Public Equities, L.P.
- Vtv Therapeutics Inc. shareholders
- Schedule 13G · Invus Public Equities, L.P. · Sep 8, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 29, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 16, 2026
- Schedule 13G · Millennium Management LLC · Mar 27, 2026
- Schedule 13D/A · Akkaraju Srinivas · Dec 9, 2025